Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2026 ∙ Doyon-Plourde, P. Chong, J. Abrams, E. M. Pless, R. Young, K. Tunis, M. Zafack, J.

Aluminium adjuvants in vaccines and potential health effects: systematic review

  • All age groups
  • Safety
Methodological quality (AMSTAR 2):
Low
2026 ∙ Cao, Q. Du, S. Yang, K. Liu, M. Xiao, L. Wang, Q. Fu, J. Zhu, H.

Assessing the impact of SARS-CoV-2 infection and vaccination on fertility and assisted reproductive techniques outcomes: an umbrella review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Danysz, M. De Aguiar, R. C. Pindolia, H. Stuart, B. Spensley, K. Ashmore, E. Frumento, N. Haouidji-Javaux, N. Hutchinson, C. Iles, R. Lau, S. Rolt, J. Uwenedi, G. Wagg, H. Barnes, E. Lim, S. H. Richter, A. Willicombe, M.

Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studies

  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2026 ∙ Yang, J. W. Jiang, J.

Association between varicella-zoster virus and Alzheimer's disease: A systematic review and meta-analysis of comprehensive evidence from infection, treatment to prevention

  • All age groups
  • Herpes zoster
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Nguyen, A. T. Duckworth, E. D. Li, R. A. Adam, T. H. Galiano, R. D.

Cervical Cancer Prevention and Treatment Disparities Among Native Hawaiian and Pacific Islanders: A Systematic Review and Meta-Analysis

  • All age groups
  • Human papillomavirus (HPV)
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Suleman, D. B. Folorunsho, S.

Cervical cancer research disparities among African immigrant women in the United States: A systematic review

  • Americas
  • United States of America
  • Adults
  • Older adults
  • Human papillomavirus (HPV)
  • Coverage
  • Acceptance
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Hayford, K. Tort, M. J. Huang, L. Forbes, C. Pustulka, I. Chapman, R. Theilacker, C.

Clinical effectiveness and impact of 13-valent pneumococcal conjugate vaccines in preventing invasive pneumococcal disease among children with risk conditions: A systematic literature review

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Khan, B. W. Khattak, M. H. Amjad, M. M. Siddiqui, S. A. Qazi, T. I. Rehmat, H. Khan, M. F. Khan, H. W. Mian, A. M. Ullah, M. Khan, U. Z. Rafay, M. A. Al-Badri, S. G. Bacha, Z.

Comparative Effectiveness of High-Dose and Standard-Dose Influenza Vaccines for Hospitalisation and Mortality in Adults Aged 65 and Older: An Updated Systematic Review and Meta-Analysis

  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Omam, L. A. Jarman, E. Malik, F. Kamwa, V. Mba, C. M.

Containment and response strategies for mpox outbreaks: a systematic review

  • All age groups
  • Mpox
  • Efficacy/effectiveness
  • Administration
  • Coverage
  • Logistics
  • Ethical issues
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Van Sassenbroeck, B. Piessens, V. Roegies, M. Vandijck, D.

Cost-effectiveness analyses of quadrivalent influenza vaccinations in the general European population-a systematic review

  • Europe
  • All age groups
  • Pregnant women
  • Healthcare workers
  • Influenza
  • Economic aspects
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
Loading...